Pharsight

AOP ORPHAN PHARMACEUTICALS AG patents facing oppositions

Top patents of AOP ORPHAN PHARMACEUTICALS AG facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2988750B1 19 Jan, 2022 Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias Apr, 2034 1